Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

US Stock Market Move | Alamar Biosciences (ALMR.US) debuts on the US stock market, opening with a gain of over 34%.

US Stock Market Move | Military drone manufacturer Aevex Corp (AVEX.US) enters the US stock market, opening up more than 20%

US Stock Market Move | Weight loss drug newcomer Kailera Therapeutics (KLRA.US) debuted on the US stock market with an opening surge of over 50%.
US Stock Market Move | Alamar Biosciences (ALMR.US) debuts on the US stock market, opening with a gain of over 34%.

US Stock Market Move | Military drone manufacturer Aevex Corp (AVEX.US) enters the US stock market, opening up more than 20%

US Stock Market Move | Weight loss drug newcomer Kailera Therapeutics (KLRA.US) debuted on the US stock market with an opening surge of over 50%.

RECOMMEND

Hong Kong Hard‑Tech Companies Enhance Canton Fair Presence As Veterans And Newcomers Expand International Networks
17/04/2026

Thousand‑Fold Oversubscription In Hong Kong IPOs Signals Multiple Market Shifts
17/04/2026

Rising Compute Costs Drive Industry Price Increases As Institutions Expect Internet Firms To Outperform In Q1
17/04/2026


